Agile Therapeutics Cash on Hand 2013-2023 | AGRX
Agile Therapeutics cash on hand from 2013 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Agile Therapeutics Annual Cash on Hand (Millions of US $) |
2023 |
$3 |
2022 |
$5 |
2021 |
$19 |
2020 |
$54 |
2019 |
$34 |
2018 |
$8 |
2017 |
$36 |
2016 |
$49 |
2015 |
$34 |
2014 |
$40 |
2013 |
$2 |
2012 |
$20 |
Agile Therapeutics Quarterly Cash on Hand (Millions of US $) |
2023-12-31 |
$3 |
2023-09-30 |
$3 |
2023-06-30 |
$3 |
2023-03-31 |
$4 |
2022-12-31 |
$5 |
2022-09-30 |
$6 |
2022-06-30 |
$13 |
2022-03-31 |
$4 |
2021-12-31 |
$19 |
2021-09-30 |
$15 |
2021-06-30 |
$31 |
2021-03-31 |
$40 |
2020-12-31 |
$54 |
2020-09-30 |
$72 |
2020-06-30 |
$87 |
2020-03-31 |
$94 |
2019-12-31 |
$34 |
2019-09-30 |
$18 |
2019-06-30 |
$11 |
2019-03-31 |
$12 |
2018-12-31 |
$8 |
2018-09-30 |
$17 |
2018-06-30 |
$22 |
2018-03-31 |
$28 |
2017-12-31 |
$36 |
2017-09-30 |
$44 |
2017-06-30 |
$34 |
2017-03-31 |
$42 |
2016-12-31 |
$49 |
2016-09-30 |
$52 |
2016-06-30 |
$59 |
2016-03-31 |
$65 |
2015-12-31 |
$34 |
2015-09-30 |
$39 |
2015-06-30 |
$46 |
2015-03-31 |
$54 |
2014-12-31 |
$40 |
2014-09-30 |
$46 |
2014-06-30 |
$53 |
2014-03-31 |
|
2013-12-31 |
|
2013-09-30 |
|
2013-06-30 |
|
2012-12-31 |
$20 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.003B |
$0.020B |
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
|